載入...
The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
The FDA-approved glucagon-like-peptide-1 receptor (GLP-1R) agonists exendin-4 and liraglutide reduce food intake and body weight. Nausea is the most common adverse side effect reported with these GLP-1R agonists. Whether food intake suppression by exendin-4 and liraglutide occurs independently of na...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4183930/ https://ncbi.nlm.nih.gov/pubmed/22227019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2011.12.022 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|